Liver transplantation

被引:20
作者
Brown, KA [1 ]
机构
[1] Henry Ford Hosp, Div Gastroenterol, Detroit, MI 48202 USA
关键词
living donor liver transplant; liver transplantation; MELD;
D O I
10.1097/01.mog.0000159830.36793.2b
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review Liver transplantation continues to-change as we further define appropriate criteria for allocation and utilization of this scarce resource. The following review highlights new trends and ideas in this evolving field. Recent findings Although the model for end-stage-renal disease (MELD) scoring system appears to fairly accurately predict mortality while waiting for transplant, the system may be less ace in predicting outcomes following transplantation. MELD scores offer an additional advantage to patients with hepatocellular carcinoma (HCC) bringing them to transplant sooner with overall better survivals However, despite its,advantages, the MELD scoring system does not resolve the. disparity in the allocation of organs between various organ procurement organizations. Several variables appear to affect patients with hepatitis C undergoing liver transplantation. Selection of appropriate donors appears to be important when transplanting patients with hepatitis C virus (HCV) infection as increasing. donor age is associated with poorer outcomes. However, the, controversy over whether a living donor liver transplant (LDLT) results in poorer outcomes in HCV infected patients remains. Post-transplant. medical treatment of HCV may in both a sustained virologic response and improved histology. With improved overall survival in patients undergoing orthrotopic liver. transplant (OLT), increasing attention has been focused on the medical complications following transplant. ldentifying specific contributing factors in the development of renal dysfunction and devising strategies to prevent its occurrence are critical to further improvements in outcome following OLT. Summary As the gap between patients and available organs remains, continued investigation into appropriate allocation and maximization of outcomes following liver transplant will continue.
引用
收藏
页码:331 / 336
页数:6
相关论文
共 38 条
[1]   Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C [J].
Abdelmalek, MF ;
Firpi, RJ ;
Soldevila-Pico, C ;
Reed, AI ;
Hemming, AW ;
Liu, C ;
Crawford, JM ;
Davis, GL ;
Nelson, DR .
LIVER TRANSPLANTATION, 2004, 10 (02) :199-207
[2]   Survival following liver transplantation from non-heart-beating donors [J].
Abt, PL ;
Desai, NM ;
Crawford, MD ;
Forman, LM ;
Markmann, JW ;
Olthoff, KM ;
Markmann, JF .
ANNALS OF SURGERY, 2004, 239 (01) :87-92
[3]   Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus [J].
Bozorgzadeh, A ;
Jain, A ;
Ryan, C ;
Ornt, D ;
Zand, M ;
Mantry, P ;
Lansing, K ;
Orloff, M .
TRANSPLANTATION, 2004, 77 (07) :1066-1070
[4]   Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation [J].
Delgado-Borrego, A ;
Casson, D ;
Schoenfeld, D ;
Somsouk, M ;
Terella, A ;
Jordan, SH ;
Bhan, A ;
Baid, S ;
Cosimi, AB ;
Pascual, M ;
Chung, RT .
TRANSPLANTATION, 2004, 77 (05) :703-710
[5]   Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function [J].
Desai, NM ;
Mange, KC ;
Crawford, MD ;
Abt, PL ;
Frank, AM ;
Markmann, JW ;
Velidedeoglu, E ;
Chapman, WC ;
Markmann, JF .
TRANSPLANTATION, 2004, 77 (01) :99-106
[6]   Living donor liver transplantation and hepatitis C [J].
Forman, LM ;
Trotter, JF ;
Emond, J .
LIVER TRANSPLANTATION, 2004, 10 (03) :347-348
[7]   Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation [J].
Garcia-Retortillo, M ;
Forns, X ;
Llovet, JM ;
Navasa, M ;
Feliu, A ;
Massaguer, A ;
Bruguera, M ;
Fuster, J ;
Garcia-Valdecasas, JC ;
Rimola, A .
HEPATOLOGY, 2004, 40 (03) :699-707
[8]   Biliary complications in 96 consecutive right lobe living donor transplant recipients [J].
Gondolesi, GE ;
Varotti, G ;
Florman, SS ;
Muñoz, L ;
Fishbein, TM ;
Emre, SH ;
Schwartz, ME ;
Miller, C .
TRANSPLANTATION, 2004, 77 (12) :1842-1848
[9]   Adult living donor liver transplantation for patients with hepatocellular carcinoma -: Extending UNOS priority criteria [J].
Gondolesi, GE ;
Roayaie, S ;
Muñoz, L ;
Kim-Schluger, L ;
Schiano, T ;
Fishbein, TM ;
Emre, S ;
Miller, CM ;
Schwartz, ME .
ANNALS OF SURGERY, 2004, 239 (02) :142-149
[10]   Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD [J].
Hayashi, PH ;
Trotter, JF ;
Forman, L ;
Kugelmas, M ;
Steinberg, T ;
Russ, P ;
Wachs, M ;
Bak, T ;
Kam, I ;
Everson, GT .
LIVER TRANSPLANTATION, 2004, 10 (01) :42-48